Skip to main content

Advertisement

Table 1 Patients’ characteristics

From: Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery

Clinicopathologic characteristics Ctrl (n = 51) DEX (n = 52) P value
Age: median (minimum–maximum), years 59 (48–67) 63 (51–74) 0.615a
Gender: female/male 21/30 23/29 0.754b
Histology: adenocarcinoma/squamous cell carcinoma 38/13 44/8 0.203b
TNM stage: II/III 23/28 18/34 0.277b
Vascular invasion: present/absent 19/32 12/40 0.117b
Tumor size: < 3 cm/> 3 cm 25/26 30/22 0.378b
Tumor number: single/multiple 33/18 40/12 0.172b
Anesthesia duration: median (minimum–maximum), minutes 226 (168–422) 238 (184–454) 0.475a
  1. aMann–Whitney U test
  2. bPearson’s Chi square test